BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Vrije Universiteit Amsterdam//NONSGML v1.0//EN
NAME:PhD defence A.C. Berrens
METHOD:PUBLISH
BEGIN:VEVENT
DTSTART:20260223T114500
DTEND:20260223T131500
DTSTAMP:20260223T114500
UID:2026/phd-defence-a-c-berrens@8F96275E-9F55-4B3F-A143-836282E12573
CREATED:20260429T094314
LOCATION:(1st floor) Auditorium, Main building De Boelelaan 1105 1081 HV Amsterdam
SUMMARY:PhD defence A.C. Berrens
X-ALT-DESC;FMTTYPE=text/html: <html> <body> <p>Tailoring Prostate Canc
 er Surgery</p> <p>This thesis studied and confirmed that image-guided
  surgery in prostate cancer is an innovative way to operate with grea
 ter precision. First, a systematic review was conducted of what was k
 nown worldwide at that time. This was studied more in depth through a
  Delphi consensus proces with international panel members. The wishes
  and requirements of daily practicioners of targeted surgery were ana
 lyzed, and gave us insights in how to proceed in future research. To 
 visualize anatomical structures, tracers can be used during surgery t
 o identify, for example, the sentinel lymph node or the lymphatic pat
 hways in their entirety from the prostate (and other organs). To remo
 ve the tumor-containing tissue while sparing healthy tissue, a tracer
  that specifically binds to the prostate-specific membrane antigen (P
 SMA) and is therefore selective for prostate cancer can be used. Both
  fluorescence and radio-guided surgery are options here. The focus of
  this thesis is on the advantages and disadvantages of fluorescence a
 nd radio-guided applications. The ultimate goal is to develop a prost
 ate-specific tracer that is both fluorescent and radioactive (hybrid)
 . The follow-up to this in the form of a “first-in-human” trial w
 ith the hybrid PSMA tracer is expected this year.</p><p>More informat
 ion on the <a href="https://hdl.handle.net/1871.1/b5dd2820-7133-426c-
 9c79-b4418e108f5a" data-new-window="true" target="_blank" rel="noopen
 er noreferrer">thesis</a></p> </body> </html>
DESCRIPTION: This thesis studied and confirmed that image-guided surge
 ry in prostate cancer is an innovative way to operate with greater pr
 ecision. First, a systematic review was conducted of what was known w
 orldwide at that time. This was studied more in depth through a Delph
 i consensus proces with international panel members. The wishes and r
 equirements of daily practicioners of targeted surgery were analyzed,
  and gave us insights in how to proceed in future research. To visual
 ize anatomical structures, tracers can be used during surgery to iden
 tify, for example, the sentinel lymph node or the lymphatic pathways 
 in their entirety from the prostate (and other organs). To remove the
  tumor-containing tissue while sparing healthy tissue, a tracer that 
 specifically binds to the prostate-specific membrane antigen (PSMA) a
 nd is therefore selective for prostate cancer can be used. Both fluor
 escence and radio-guided surgery are options here. The focus of this 
 thesis is on the advantages and disadvantages of fluorescence and rad
 io-guided applications. The ultimate goal is to develop a prostate-sp
 ecific tracer that is both fluorescent and radioactive (hybrid). The 
 follow-up to this in the form of a “first-in-human” trial with th
 e hybrid PSMA tracer is expected this year. More information on the <
 a href="https://hdl.handle.net/1871.1/b5dd2820-7133-426c-9c79-b4418e1
 08f5a" data-new-window="true" target="_blank" rel="noopener noreferre
 r">thesis</a> Tailoring Prostate Cancer Surgery
END:VEVENT
END:VCALENDAR
